Charles Thompson
Overview
Explore the profile of Charles Thompson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
872
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thompson C, Chandra K
J Acoust Soc Am
. 2022 Jan;
150(6):4548.
PMID: 34972308
Acoustic streaming resulting from the time-harmonic compression of the cochlear capsule is examined in this paper. The cochlear pressure is expressed as an integral equation in the cochlear partition velocity....
2.
Friend J, Thompson C, Chitale K, Denis M
J Acoust Soc Am
. 2022 Jan;
150(6):4558.
PMID: 34972297
Acoustofluidics is a burgeoning field that applies ultrasound to micro-scale to nano-scale fluidic systems. The discovery of the ability to effectively manipulate fluids and particles at small scales has yielded...
3.
Hu L, Thompson C, Remillard G, Chandra K
J Acoust Soc Am
. 2021 Sep;
150(2):1133.
PMID: 34470288
In this work, the physical processes that govern the operation of a passive acoustic transducer are analyzed and modeled. The wireless battery-free transducer derives its power from an externally applied...
4.
Chan W, Thurairajah P, Butcher N, Oosterwijk C, Wever K, Eichler I, et al.
Arch Dis Child
. 2020 Mar;
105(9):875-880.
PMID: 32209556
Background: Engaging patients and the public as collaborators in research is increasingly recognised as important as such partnerships can help improve research relevance and acceptability. Young Persons' Advisory Groups (YPAGs)...
5.
Tsang V, West L, Woods C, Koh C, McCune S, Mullin T, et al.
Ther Innov Regul Sci
. 2019 Jan;
53(5):601-608.
PMID: 30663334
Patient engagement in health care has been an emerging priority in the global effort and move toward the consideration of patients as experts of their own conditions. However, the input...
6.
Calderon-Garciduenas L, Mukherjee P, Waniek K, Holzer M, Chao C, Thompson C, et al.
J Alzheimers Dis
. 2018 Nov;
66(4):1437-1451.
PMID: 30412505
Long-term exposure to fine particulate matter (PM2.5) and ozone (O3) above USEPA standards is associated with Alzheimer's disease (AD) risk. Metropolitan Mexico City (MMC) children exhibit subcortical pretangles in infancy...
7.
Thompson C, Lombardi D, Sjostedt P, Squires L
Ther Innov Regul Sci
. 2018 Sep;
49(5):647-658.
PMID: 30227032
The palatability of oral drugs influences patient adherence to prescribed regimens, especially for children. Various factors influence palatability, including smell, taste, texture, and dose volume. Evaluation of these factors plays...
8.
Thompson H, Frederico N, Smith S, Chowdhury M, Dicks P, Preston J, et al.
Ther Innov Regul Sci
. 2018 Sep;
49(5):673-679.
PMID: 30227029
Research and innovation are critical to improving the health and well-being of the world's children; clinical trials yield important information on a medical product's safety, dosing, and effectiveness. While the...
9.
Lombardi D, Squires L, Sjostedt P, Eichler I, Turner M, Thompson C
Ther Innov Regul Sci
. 2018 May;
52(1):29-37.
PMID: 29714610
Background: Obtaining assent from children participating in clinical trials acknowledges autonomy and developmental ability to contribute to the consent process. This critical step in pediatric drug development remains poorly understood,...
10.
Calderon-Garciduenas L, Avila-Ramirez J, Calderon-Garciduenas A, Gonzalez-Heredia T, Acuna-Ayala H, Chao C, et al.
J Alzheimers Dis
. 2016 Aug;
54(2):597-613.
PMID: 27567860
Exposure to fine particulate matter (PM2.5) and ozone (O3) above US EPA standards is associated with Alzheimer's disease (AD) risk, while Mn toxicity induces parkinsonism. Mexico City Metropolitan Area (MCMA)...